146 related articles for article (PubMed ID: 9257326)
1. 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies.
Bergström M; Westerberg G; Långström B
Nucl Med Biol; 1997 May; 24(4):287-93. PubMed ID: 9257326
[TBL] [Abstract][Full Text] [Related]
2. MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography.
Bergström M; Westerberg G; Németh G; Traut M; Gross G; Greger G; Müller-Peltzer H; Safer A; Eckernäs SA; Grahnér A; Långström B
Eur J Clin Pharmacol; 1997; 52(2):121-8. PubMed ID: 9174681
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain.
Bergström M; Westerberg G; Kihlberg T; Långström B
Nucl Med Biol; 1997 Jul; 24(5):381-8. PubMed ID: 9290071
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of monoamine oxidase A and B type enzyme occupancy using non-radiolabelled tracers in rat brain.
Thentu JB; Bhyrapuneni G; Padala NP; Chunduru P; Pantangi HR; Nirogi R
Neurochem Int; 2021 May; 145():105006. PubMed ID: 33636211
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain.
Ginovart N; Meyer JH; Boovariwala A; Hussey D; Rabiner EA; Houle S; Wilson AA
J Cereb Blood Flow Metab; 2006 Mar; 26(3):330-44. PubMed ID: 16079787
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain.
Maschauer S; Haller A; Riss PJ; Kuwert T; Prante O; Cumming P
J Neurochem; 2015 Dec; 135(5):908-17. PubMed ID: 26386360
[TBL] [Abstract][Full Text] [Related]
7. 11C-harmine as a potential PET tracer for ductal pancreas cancer: in vitro studies.
Herlin G; Persson B; Bergström M; Långström B; Aspelin P
Eur Radiol; 2003 Apr; 13(4):729-33. PubMed ID: 12664110
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.
Sacher J; Houle S; Parkes J; Rusjan P; Sagrati S; Wilson AA; Meyer JH
J Psychiatry Neurosci; 2011 Nov; 36(6):375-82. PubMed ID: 21463543
[TBL] [Abstract][Full Text] [Related]
9. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
Jensen SB; Olsen AK; Pedersen K; Cumming P
Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.
Ametamey SM; Beer HF; Guenther I; Antonini A; Leenders KL; Waldmeier PC; Schubiger PA
Nucl Med Biol; 1996 Apr; 23(3):229-34. PubMed ID: 8782230
[TBL] [Abstract][Full Text] [Related]
11. Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography.
Goller L; Bergstrom M; Nilsson S; Westerberg G; Langstrom B
Oncol Rep; 1995 Sep; 2(5):717-21. PubMed ID: 21597803
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine.
Orlefors H; Sundin A; Fasth KJ; Oberg K; Långström B; Eriksson B; Bergström M
Nucl Med Biol; 2003 Aug; 30(6):669-79. PubMed ID: 12900293
[TBL] [Abstract][Full Text] [Related]
13. Quantitative distribution of rat brain monoamine oxidase A by [14C]clorgyline autoradiography.
Kondoh Y; Murakami M; Yin W; Mizusawa S; Nakamichi H; Nagata K
Exp Brain Res; 1994; 99(3):375-8. PubMed ID: 7957717
[TBL] [Abstract][Full Text] [Related]
14. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
Waldmeier PC; Stöcklin K
Eur J Pharmacol; 1990 May; 180(2-3):297-304. PubMed ID: 2365007
[TBL] [Abstract][Full Text] [Related]
15. Non-MAO A binding of clorgyline in white matter in human brain.
Fowler JS; Logan J; Ding YS; Franceschi D; Wang GJ; Volkow ND; Pappas N; Schlyer D; Gatley SJ; Alexoff D; Felder C; Biegon A; Zhu W
J Neurochem; 2001 Dec; 79(5):1039-46. PubMed ID: 11739617
[TBL] [Abstract][Full Text] [Related]
16. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.
Fowler JS; MacGregor RR; Wolf AP; Arnett CD; Dewey SL; Schlyer D; Christman D; Logan J; Smith M; Sachs H
Science; 1987 Jan; 235(4787):481-5. PubMed ID: 3099392
[TBL] [Abstract][Full Text] [Related]
17. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A.
Mukherjee J; Yang ZY
Nucl Med Biol; 1999 Aug; 26(6):619-25. PubMed ID: 10587099
[TBL] [Abstract][Full Text] [Related]
18. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Gerardy J
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
[TBL] [Abstract][Full Text] [Related]
19. [
Zanderigo F; D'Agostino AE; Joshi N; Schain M; Kumar D; Parsey RV; DeLorenzo C; Mann JJ
Mol Imaging Biol; 2018 Aug; 20(4):667-681. PubMed ID: 29423903
[TBL] [Abstract][Full Text] [Related]
20. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
